Back to Trades
Total Value
$1.2M
Net $784.8K sold
Filing Date
Jul 9, 2026
1 transaction
Sales
$784.8K
1 transaction
Trade Summary
On Jul 8, 2026, Metzger Michael A, Insider, sold $1.2M of Syndax Pharmaceuticals Inc (SNDX) across 1 transaction. The filing covers Common Stock and reflects net selling of $784.8K. Reported prices ranged from $6.38 to $24.24. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- Syndax Pharmaceuticals Inc
- Ticker Symbol
- SNDX
- CIK
- 0001395937
Insider Information
- Role
- Insider
- Location
- NEW YORK, NY
Filing Details
- Filing Date
- Jul 9, 2026
- Transaction Date
- Jul 8, 2026
- Accession Number
- 0001193125-26-299803
- Form Type
- 4
- Net Trading Amount
- -$784.8K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jul 8, 2026 | Common Stock | 32,375 | $6.38 | Exercise | $206.6K |
| Jul 8, 2026 | Common Stock | 32,375 | $24.24 | Sale | $784.8K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Jul 8, 2026 | SNDX derivative | 32,375 | $6.38 | Exercise | $206.6K |
Want live alerts when Metzger Michael A trades again?
Download Insider Trades to track SNDX, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Following the sales reported in this Form 4, the Reporting Person has a total of 1,564,551 options to purchase shares of common stock that are vested and immediately exercisable and a total of 813,949 options to purchase shares of common stock that have not yet vested.
- (F2)The sale prices ranged from $24.00 to $24.43
- (F3)This option is fully vested.